Research Article

Hypomethylation of IL10 and IL13 Promoters in CD4+ T Cells of Patients with Systemic Lupus Erythematosus

Table 1

Patient demographics, medications.

PatientSex/AgeSLEDAI scoreMedication

1F/356Pred 20 mg/d
2F/334None
3F/2210Pred 40 mg/d
4F/276Tria 8 mg/d
5F/296None
6F/2616TG 40 mg/d
7F/3212Pred 35 mg/d
8F/188None
9F/244Pred 10 mg/d
10F/3011Pred 20 mg/d
11F/3116Pred 40 mg/d
12F/236Tria 16 mg/d
13F/4310Pred 20 mg/d
14F/4114Pred 30 mg/d
15F/2910Pred 25 mg/d

F, female; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; Pred: Prednisone; Tria: Triamcinolone; TG: Tripterygium Glycosides.